The Prognostic Values of Signal Transducers Activators of Transcription Family in Ovarian Cancer

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2017 May 25

PMID 28536310

Citations 18

Authors

Saisai Li

Bo Sheng

Menghuang Zhao

Qi Shen

Haiyan Zhu

Xueqiong Zhu

Affiliations

Soon will be listed here.

Abstract

Signal transducer and activator of transcription (STAT), a family of latent cytoplasmic transcription factors, are composed of seven identified members (STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, STAT6). STATs are associated with several biological processes such as cell proliferation, invasion, and metastasis in various cancer types. In addition, the STAT family has been well studied as a prognostic predictor for a considerable number of solid tumors. However, the prognostic value of the STAT family in ovarian cancer patients remains unclear. In our present study, we intend to access the prognostic roles of the STAT family in ovarian carcinoma through the 'Kaplan-Meier plotter' (KM plotter) online database, which collected gene expression data and survival information (overall survival (OS)) from a total of 1582 ovarian cancer patients. Our results show that high mRNA expression of , and , are correlated to a better OS of ovarian cancer patients, especially the high level of and are significantly related to a favorable OS for serous ovarian cancer patients. We further accessed the prognostic roles of individual in other clinicopathological features, such as pathological grades, clinical stages, and TP53 mutation, and found that these genes indicate a favorable prognosis especially for late stage, poor differentiation, and TP53 mutated ovarian cancer patients. In conclusion, these results suggest that the STAT family plays a significant prognostic role in ovarian carcinoma and individual STATs, except STAT2 and STAT3, may act as favorable prognostic markers in ovarian cancer.

Citing Articles

STAT4 facilitates PD-L1 level via IL-12R/JAK2/STAT3 axis and predicts immunotherapy response in breast cancer.

Zhou J, Wan F, Wang L, Peng C, Huang R, Peng F MedComm (2020). 2023; 4(6):e464.

PMID: 38107057 PMC: 10724500. DOI: 10.1002/mco2.464.

Expression and prognostic role of STAT5a across cancer types.

Maninang C, Li J, Li W Biosci Rep. 2023; 43(8).

PMID: 37369132 PMC: 10407157. DOI: 10.1042/BSR20230612.

, a potential predictor of prognosis, promotes CD8 T‑cell infiltration in ovarian serous carcinoma by inducing CCL5 secretion.

Wang W, Liu S, Lu F, Yang B, Zhuang X, Yin J Oncol Rep. 2023; 50(1).

PMID: 37264954 PMC: 10251369. DOI: 10.3892/or.2023.8577.

Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.

Nie S, Ni N, Chen N, Gong M, Feng E, Liu J J Ovarian Res. 2023; 16(1):82.

PMID: 37095524 PMC: 10127035. DOI: 10.1186/s13048-023-01155-9.

Comprehensive analysis of the prognostic and immunotherapeutic implications of STAT family members in human colorectal cancer.

Li D, Jiao Y, Gao W, Hu S, Li D, Zhao W Front Genet. 2022; 13:951252.

PMID: 36061181 PMC: 9437353. DOI: 10.3389/fgene.2022.951252.

References

Setsu N, Kohashi K, Endo M, Yamamoto H, Tamiya S, Takahashi Y . Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis. Int J Cancer. 2012; 132(1):109-15. DOI: 10.1002/ijc.27655. View

Simpson J, Al-Attar A, Watson N, Scholefield J, Ilyas M, Durrant L . Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer. Gut. 2010; 59(7):926-33. DOI: 10.1136/gut.2009.194472. View

Darnell Jr J, Kerr I, Stark G . Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994; 264(5164):1415-21. DOI: 10.1126/science.8197455. View

Wang C, Ye Y, Yuan J, Liu F, Zhang H, Wang S . EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis. World J Gastroenterol. 2010; 16(19):2421-7. PMC: 2874149. DOI: 10.3748/wjg.v16.i19.2421. View

Aleskandarany M, Agarwal D, Negm O, Ball G, Elmouna A, Ashankyty I . The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts. Breast Cancer Res Treat. 2016; 156(1):9-20. DOI: 10.1007/s10549-016-3709-z. View

Widschwendter A, Welte T, Daxenbichler G, Marth C, Doppler W . Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res. 2002; 8(10):3065-74. View

Blaszczyk K, Nowicka H, Kostyrko K, Antonczyk A, Wesoly J, Bluyssen H . The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses. Cytokine Growth Factor Rev. 2016; 29:71-81. DOI: 10.1016/j.cytogfr.2016.02.010. View

Sadowski H, Shuai K, Darnell Jr J, Gilman M . A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science. 1993; 261(5129):1739-44. DOI: 10.1126/science.8397445. View

Zhong Z, Wen Z, Darnell Jr J . Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994; 264(5155):95-8. DOI: 10.1126/science.8140422. View

10.

Huang M, Page C, Reynolds R, Lin J . Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol Oncol. 2000; 79(1):67-73. DOI: 10.1006/gyno.2000.5931. View

11.

Koti M, Siu A, Clement I, Bidarimath M, Turashvili G, Edwards A . A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer. Br J Cancer. 2015; 113(12):1746. PMC: 4702007. DOI: 10.1038/bjc.2015.459. View

12.

Vergote I, Trope C, Amant F, Kristensen G, Ehlen T, Johnson N . Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010; 363(10):943-53. DOI: 10.1056/NEJMoa0908806. View

13.

Nevalainen M, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J . Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol. 2004; 22(11):2053-60. DOI: 10.1200/JCO.2004.11.046. View

14.

Gordziel C, Bratsch J, Moriggl R, Knosel T, Friedrich K . Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma. Br J Cancer. 2013; 109(1):138-46. PMC: 3708576. DOI: 10.1038/bjc.2013.274. View

15.

Peck A, Witkiewicz A, Liu C, Stringer G, Klimowicz A, Pequignot E . Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. J Clin Oncol. 2011; 29(18):2448-58. PMC: 3675698. DOI: 10.1200/JCO.2010.30.3552. View

16.

He Y, Zhou Z, Hofstetter W, Zhou Y, Hu W, Guo C . Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters. PLoS One. 2012; 7(2):e31087. PMC: 3277494. DOI: 10.1371/journal.pone.0031087. View

17.

Rosen D, Mercado-Uribe I, Yang G, Bast Jr R, Amin H, Lai R . The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer. 2006; 107(11):2730-40. DOI: 10.1002/cncr.22293. View

18.

Levy D, Darnell Jr J . Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002; 3(9):651-62. DOI: 10.1038/nrm909. View

19.

Gyorffy B, Surowiak P, Budczies J, Lanczky A . Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One. 2013; 8(12):e82241. PMC: 3867325. DOI: 10.1371/journal.pone.0082241. View

20.

Sun Y, Yang S, Sun N, Chen J . Differential expression of STAT1 and p21 proteins predicts pancreatic cancer progression and prognosis. Pancreas. 2014; 43(4):619-23. DOI: 10.1097/MPA.0000000000000074. View